Related Experiment Videos
Cardiovascular risk factors in chronic renal failure and hemodialysis populations
1Department of Medicine, Veterans Administration Medical Center, Minneapolis, MN 55417.
Insights
Cardiovascular disease is a major concern for patients with end-stage renal disease (ESRD). Early intervention targeting risk factors like hypertension and lipid abnormalities may reduce cardiovascular complications in chronic kidney disease.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Cardiovascular disease (CVD) is the primary cause of mortality in end-stage renal disease (ESRD) patients.
- Risk factors for CVD, such as hypertension, dyslipidemia, left ventricular hypertrophy (LVH), and glucose intolerance, are more prevalent in chronic kidney disease (CKD) patients, even before dialysis.
- These factors contribute significantly to the high cardiovascular burden in the uremic population.
Purpose of the Study:
- To examine the prevalence, pathogenesis, and clinical significance of CVD risk factors in patients with chronic renal failure.
- To review the potential benefits of interventions aimed at modifying these risk factors.
- To highlight the need for further research into the impact of risk factor modification on cardiovascular outcomes in early-stage CKD.
Main Methods:
- Literature review and analysis of existing evidence.
- Examination of epidemiological data on CVD risk factors in CKD.
- Synthesis of current understanding regarding the pathophysiology of CVD in ESRD.
Main Results:
- Hypertension, lipid abnormalities, LVH, and glucose intolerance are frequently observed in patients with chronic renal failure.
- The predictive value of these factors for cardiovascular complications in CKD is suggested but not definitively proven.
- Intervention strategies for managing these risk factors are under review for their potential impact.
Conclusions:
- Cardiovascular risk factors are highly prevalent in patients with chronic renal failure and contribute to increased mortality.
- Further research is crucial to establish the conclusive predictive value of these factors and the efficacy of interventions in mitigating cardiovascular morbidity and mortality, particularly in the early stages of renal disease.
Abstract:
Cardiovascular disease is the leading cause of death in patients with end-stage renal disease (ESRD). Risk factors for cardiovascular disease, including hypertension, lipid abnormalities, left ventricular hypertrophy (LVH), and glucose intolerance, are present more frequently in patients with chronic renal failure than in the general population, even before the onset of replacement therapy. The prevalence, pathogenesis, and significance of these factors in the uremic population are examined, and the potential roles of intervention are reviewed. Evidence suggests, but is not conclusive, that these factors are of predictive value for cardiovascular complications in patients with chronic renal failure. The effect of modification of these factors on cardiovascular morbidity and mortality in this population, especially in the early stages of renal failure, is an important area for further study.